Suppr超能文献

采用汗-皮脂乳剂提取作为基于贴剂的医疗器械中浸出物的新检测方法,以评估糖尿病产品中的异冰片丙烯酸酯(IBOA)为例。

Extraction With Sweat-Sebum Emulsion as a New Test Method for Leachables in Patch-Based Medical Devices, Illustrated by Assessment of Isobornylacrylate (IBOA) in Diabetes Products.

机构信息

Roche Diabetes Care GmbH, Mannheim, Germany.

Steinbeis Innovationszentrum für Zellkulturtechnik, Mannheim, Germany.

出版信息

J Diabetes Sci Technol. 2021 Jul;15(4):792-800. doi: 10.1177/1932296820908656. Epub 2020 Mar 1.

Abstract

BACKGROUND

The increasing offering of patch-based medical devices is accompanied by growing numbers of reported adverse skin reactions. Procedures for testing leachables according to ISO 10993 may not be optimal for lipophilic substances that can be mobilized on skin by sweat and sebum. We propose an improved extraction method for targeted analysis of leachables using low volumes of a sweat-sebum emulsion. The approach is illustrated by the analysis of isobornylacrylate (IBOA), a compound found in some devices and suspected for allergenic potential.

METHOD

Three patch-based products were tested: an implantable device for continuous glucose monitoring (CGM), an intermittently scanned CGM (isCGM) device, and a micro-insulin pump. Quantification of IBOA was performed by gas chromatography and allergenic potential of IBOA levels was assessed by the KeratinoSens cell assay. Different combinations were used for extraction solvent (isopropanol, 5% ethanol-water solution, and sweat-sebum emulsion), extraction volumes (complete immersion vs partial immersion in 2 mm of solvent), and extraction time (3, 5, and 14 days).

RESULTS

Isobornylacrylate was only found in the isCGM device. About 20 mg/L IBOA were eluted after 3 days in isopropanol but only about 1 mg/L in ethanol-water. Sweat-sebum emulsion dissolves IBOA better and gives a more stable solution than ethanol-water. Decomposition of IBOA solutions requires adjusted extraction timing or correction of results. In the sweat-sebum extract, IBOA levels were about 20 mg/L after 3 days and about 30 mg/L after 5 days, clearly above the threshold found in the KerationSens assay for keratinocyte activation (10 mg/L).

CONCLUSION

Extraction by low volumes of sweat-sebum emulsion can be a superior alternative for the targeted simulating-use assessment of leachables in patch-based medical devices.

摘要

背景

随着贴剂式医疗器械的不断增加,报告的不良皮肤反应数量也在不断增加。根据 ISO 10993 进行浸出物测试的程序可能并不适用于亲脂性物质,这些物质可能会被汗液和皮脂从皮肤中动员出来。我们提出了一种使用低体积的汗液-皮脂乳液对贴剂式医疗器械中的浸出物进行靶向分析的改进提取方法。该方法通过对异冰片丙烯酸酯(IBOA)的分析得到了说明,IBOA 是一些器械中发现的一种化合物,有疑似致敏的潜在风险。

方法

对三种贴剂式产品进行了测试:一种用于连续血糖监测(CGM)的植入式设备、一种间歇性扫描 CGM(isCGM)设备和一种微型胰岛素泵。通过气相色谱法对 IBOA 进行定量,并通过 KeratinoSens 细胞测定法评估 IBOA 水平的致敏潜力。提取溶剂(异丙醇、5%乙醇-水溶液和汗液-皮脂乳液)、提取体积(完全浸入与 2mm 溶剂部分浸入)和提取时间(3、5 和 14 天)采用了不同的组合。

结果

IBOA 仅在 isCGM 设备中发现。在异丙醇中 3 天后洗脱约 20mg/L 的 IBOA,但在乙醇-水溶液中仅洗脱约 1mg/L。与乙醇-水溶液相比,汗液-皮脂乳液能更好地溶解 IBOA,并提供更稳定的溶液。IBOA 溶液的分解需要调整提取时间或对结果进行修正。在汗液-皮脂提取物中,3 天后 IBOA 水平约为 20mg/L,5 天后约为 30mg/L,明显高于 KerationSens 测定角化细胞激活的阈值(10mg/L)。

结论

使用低体积的汗液-皮脂乳液提取可以作为替代方法,用于对贴剂式医疗器械中的浸出物进行模拟使用评估。

相似文献

本文引用的文献

8
Dermal bioaccessibility of plasticizers in indoor dust and clothing.室内灰尘和衣物中增塑剂的皮肤生物可给性。
Sci Total Environ. 2019 Jul 1;672:798-805. doi: 10.1016/j.scitotenv.2019.04.028. Epub 2019 Apr 3.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验